This leaflet's format was set and its contents inspected and approved by the Ministry of Health
|
|
- Prosper Garrett
- 5 years ago
- Views:
Transcription
1 This leaflet's format was set and its contents inspected and approved by the Ministry of Health Patient leaflet in accordance with the Pharmacists Regulation (Preparations) 1986 The preparation shall be sold only with a doctor's prescription Betoptic S Sterile Ophthalmic Suspension Composition: 1 ml contains: Betaxolol, Betaxolol HCI (as base 0.25%) Excipients appear at the end of the leaflet. Read this leaflet in its entirety before using the medication. This leaflet contains concise information on the medication. If you have additional questions, ask the physician or pharmacist. This medication was prescribed for you. Do not share it with others. It may harm them, even if you think their medical condition is similar. This medication is not for use in children and adolescents under the age of 18 years since the safety and efficiency of the medication has not been evaluated in this population. 1. What is the medication used for? Betoptic S is used to reduce pressure in the eye and treat open-angle glaucoma. Therapeutic group: Beta-blockers, drug to reduce pressure in the eye. 2. Before using the medication Do not use the medication if: Do not use if there is a known sensitivity to one of the medication s ingredients (see section 6). You suffer from slowed heart rate, heart failure, cardiac arrhythmia. If you suffer from or have a history of respiratory impairment such as: severe asthma, chronic obstructive pulmonary disease, severe COPD that might cause wheezing, difficulty breathing and/or chronic cough). Warning: Consult a physician when switching to treatment with this preparation, for dose adjustment. Undergo intraocular pressure tests during treatment with this medication. If you are about to have surgery (including dental), inform the surgeon that you are taking the medication. Special warning concerning use of the medication Before treatment with Betoptic S, inform the physician if: You suffer from or have a history of coronary heart disease (symptoms may include chest pains and/or pressure, shortness of breath or asphyxiation), heart failure or hypotension. You suffer from or have a history of cardiac arrhythmia such as slow heart rate (bradycardia). You suffer from or have a history of respiratory disorders, asthma and/or chronic obstructive pulmonary disease, COPD (that might cause wheezing, difficulty breathing and/or chronic cough). You suffer from or have a history of impaired blood circulation (such as Raynaud s disease or Raynaud s syndrome). You suffer from diabetes, since Betoptic S might hide signs and symptoms of hypoglycemia. You suffer from hyperthyroidism since Betoptic S might hide the signs and symptoms of this condition.
2 You suffer from closed angle glaucoma. You suffer from or have a history of dry eyes (Sicca syndrome). If you are taking, or if you have recently taking other medications including over-the-counter medications and nutritional supplements, inform the physician or pharmacist. In particular, if you are taking or intend to take: Medications for lowering blood pressure Heart medications Diabetes medications Medications for treating emotional, behavioral and/or mental problems (such as anxieties or depression) Any other medication (including over-the-counter medications) Betoptic S might reduce the effect of Adrenalin (indicated to treat acute symptoms of allergic reactions anaphylaxis). Inform the physician or pharmacist of a history of anaphylaxis or allergic reactions. Pregnancy and breastfeeding: Pregnancy: Do not use Betoptic S if you are pregnant without consulting a physician. Breastfeeding: Do not use Betoptic S if you are breastfeeding without consulting a physician. Driving and using machinery: If your vision is blurred after using the medication, do not drive or operate machinery until your vision clears up. Important information on some of the medication s components: Do not use this preparation while wearing soft contact lenses. The preparation contains the preservative Benzlakonium chloride, that change the color of soft contact lenses. Remove the lenses before using this preparation and wear them again no less than 15 minutes after instilling the medication into the eye. 3. How should you use the medication? Always use as instructed by the physician. Check with the physician or pharmacist if you are unsure. Dose and manner of treatment will be determined by the physician only. The standard dose is normally one drop twice a day. Do not exceed the recommended dose. Do not swallow. This medication is for external use only. Thoroughly shake the bottle before use. Medication instructions for use: To prevent contamination of the solution make sure that the bottle s tip does not come into contact with any surface (including the eye itself). Keep the bottle closed tightly. The drop bottle may not be full; this is to allow better control of the rate of instilment. How to use the drops: First, wash your hands. Tilt your head back. With your index finger, pull the lower eyelid down, to create a type of pocket (illustration 1). Instill the medication into the pocket. Close your eyes gently. Do not blink. Keep your eyes closed for 1 to 2 minutes. Do not squeeze the bottle, a gentle press of the bottle s base is enough to release the drop (illustration 2). In addition to the above instructions immediately after instilling the drops into the eye, press the inner corner of the eye with your middle finger. Continue applying pressure for 1 to 2 minutes after instilling into the eye.
3 This action helps preventing the medication from being absorbed into the body, thereby help prevent side effects (illustration 3). Repeat the above actions in the other eye, if the doctor instructed treatment in both eyes. After using the medication, wash your hands to cleanse them from leftover medication. To avoid spreading infection, do not use the same medication container for more than one person. If a drop missed the eye, try again. If you accidentally took a higher dose, wash the eye with warm water. Do not apply another dose until the time of the next dose. If you accidentally took an overdose or if a child accidentally swallowed from the medication, see a physician or go the hospital emergency room immediately and bring the medication package with you. If you forgot to take the medication at the scheduled time, do not take a double dose. Take a dose immediately when you remember, but if you remembered at a time close to the next dose, skip the missed dose and continue to the next dose If you are using other eye drops, wait at least 5 minutes between the administration of this medication and the administration of other eye drops. Use eye ointments last. Use this medication at regular times as instructed by the treating physician. If you forgot to take this medication at the scheduled time, take a dose immediately when you remember; do not take two doses at the same time under any circumstances 4. Side effects As with any medication, use of Betoptic S might cause side effects in some users. Do not be alarmed to read the list of side effects. You may experience none of them. You can continue using this preparation as long as the side effects are not severe. If you are concerned, consult the physician or the pharmacist. Do not stop treatment with Betoptic S without consulting the physician.
4 As with any ophthalmic medication, Betaxolol is absorbed in the blood. This might cause side effects similar to those seen with injectable or oral beta blockers. The frequency of side effects following use of beta blockers for eye diseases is lower than those experienced with medications that are injected or ingested. The side effects listed in this leaflet include reactions caused by taking eye drops that contain Betaxolol or preparations that contain other beta blockers for the treatment of eye diseases. The following side effects were seen in the clinical trials conducted for the preparation Betoptic S Very common side effects (appearing in more than one user in ten): Eye discomfort (including sensation of foreign body in the eye) Common side effects (appearing in 1-10 users in 100): Blurred vision, teary eyes Headaches Uncommon side effects (appearing in 1-10 users in 1000): Eye surface inflammation, conjunctivitis or symptoms of conjunctivitis, impaired vision, sensitivity to light. Pain, dryness and/or tired eye, excessive blinking, tingling, redness and/or swelling in the eyes. Sensation of foreign body in the eye, eye itching, eye secretions, eyelid secretions, red eyes. Irregularly slow or increased heart rate. Asthma, difficulty breathing, nasal congestion Nausea Rare side effects (appearing in 1-10 users in 10000): Cataract, reduced eye sensitivity, blepharitis Anxiety, insomnia, depression Fainting Hypotension Cough Runny nose Taste disorders Skin inflammation, itching or rash, hair loss Reduced libido The following side effects were reported by people who used eye drops containing Betaxolol, whose frequency cannot be determined from available data: Hypersensitivity reactions Dizziness Altered in rhythm or rate of heart beats Loss or absence of strength Additional side effects reported following use of other ophthalmic beta blockers which might appear upon using Betoptic S: Unknown frequency: General allergic reactions, including: swelling under the skin (which might occur in areas such as face and limbs and can obstruct respiratory tracts, resulting in difficulty swallowing or breathing), hives (itchy rash), local and generalized rash, itching, sudden serious life-threatening allergic reaction. Hypoglycemia. Nightmares, memory loss, hallucinations, delusions and confusion.
5 Stroke, impaired blood flow to the brain, increased signs and symptoms of myasthenia gravis (muscle weakness disease), abnormal sensations (such as pins and needles) Detachment of the layer under the retina which might cause vision disorders, cornea abrasion (damage to the front layer of the eyeball), upper eyelid drop (which causes the eye to be half closed), diplopia. Chest pains, palpitations, edema (accumulation of fluids), heart failure (heart disease accompanied by shortness of breath and swelling of legs due to fluid accumulation), cardiac arrhythmia, heart attack. Raynaud s syndrome, cold blue-colored hands and legs, pains in legs (particularly if there is a history of impaired blood flow). Constriction of respiratory tracts in the lungs (primarily in patients with an underlying disease). Dyspepsia, diarrhea, dryness in mouth, abdominal pains, vomiting. Skin rash with a silver-white appearance (psoriasiform rash) or exacerbation of psoriasis. Muscle pains not resulting from physical exercise. Sexual function problems, impotency. Fatigue. Increase in anti-nuclei antibodies was seen in patients using eye medications containing beta blockers. If one of the side effects worsens, or when you experience a side effects not mentioned in the leaflet, consult the physician. Reporting of suspected adverse reactions Suspected adverse events should be reported to the Ministry of Health according to the National Regulation by clicking on the link Adverse Drug Reactions Report on the Ministry of Health s website ( which directs to the online form for reporting adverse events. 5. How to store the medication? Prevent poisoning! This medication and any other medication should be kept in a closed place out of the reach of children and/or infants, preventing poisoning. Do not induce vomiting without explicit instruction from the physician. Do not use the medication after the expiry date (exp. date) imprinted on the carton/label. The expiry date refers to the last day of that month. Storage conditions: Store at a temperature below 30 C Do not use the medication after 28 days have p[assed from the time you first opened the bottle Do not keep different medications in the same package. Store the bottle in the outer carton box to protect from light. 6. Additional information: In addition to the active substance, the medication also contains: Polystyrene divinylbenzene sulfonic acid, carbomer 974P, boric acid, mannitol, disodium edetate, benzalkonium chloride, N-laurylsarcosine, hydrochloric acid, sodium hydroxide, purified water Medication s appearance and package contents: Plastic bottle containing 5 ml of milky/colourless liquid. Registration owner: Lapidot Medical Import and Marketing Ltd., 8 Hashita St., Caesarea Industrial Area, Manufacturer: Alcon Couvrer, Puurs, Belgium This leaflet was reviewed and approved by the Ministry of Health on: Medication s registration no. in the National Medication Register at the Ministry of Health:
TIMALEN 0.5% eye drops
PACKAGE LEAFLET: INFORMATION FOR THE USER TIMALEN 0.5% eye drops TIMOLOL (AS TIMOLOL MALEATE) This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationPackage leaflet: Information for the patient BETAXOLOL 0.5% EYE DROPS. Betaxolol (as hydrochloride)
Package leaflet: Information for the patient BETAXOLOL 0.5% EYE DROPS Betaxolol (as hydrochloride) Read all of this leaflet carefully before you starts to using this medicine because it contains important
More informationBrinzoQuin Eye Drops 1.0%
BrinzoQuin Eye Drops 1.0% Brinzolamide Consumer Medicine Information What Is In This Leaflet Read this leaflet carefully before you start to use BrinzoQuin Eye Drops. This leaflet has been written to answer
More informationPackage Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone
Package Leaflet - Information for the User TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone Read all of this leaflet carefully before you start using this medicine because it
More informationDorzolamide 20 mg/ml Eye Drops, Solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac
Package leaflet: Information for the user NEVANAC 1 mg/ml eye drops, suspension Nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP Read this carefully before you start taking IOPIDINE 1% and each
More informationIOPIDINE 5mg/ml Eye Drops, solution contain apraclonidine (as hydrochloride) as the active substance.
Package Leaflet - Information for the User IOPIDINE 5 mg/ml eye drops, solution Apraclonidine (as hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains
More informationPATIENT INFORMATION LEAFLET
Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 Proprietary name, Strength and Pharmaceutical Form LUMIGAN 0,03 % Eye Drops (each ml contains bimatoprost 0,3 mg) Read all of this leaflet
More informationNEVANAC TM 0.1% Eye Drops
NEVANAC TM 0.1% Eye Drops Nepafenac CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you use Nevanac Eye This leaflet answers some common questions about
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. T-LO Timolol Ophthalmic Solution (0.25%, 0.
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr T-LO Timolol Ophthalmic Solution (0.25%, 0.5% w/v) Pr TIMOLOL MALEATE-EX Timolol Ophthalmic Gel Forming Solution
More informationACULAR EYE DROPS 5 mg/ml Eye Drops
ACULAR EYE DROPS 5 mg/ml Eye Drops (ketorolac trometamol) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ACULAR eye drops, including how to use the
More informationPackage leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate
Package leaflet: Information for the user PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate Read all of this leaflet carefully before you start using this medicine
More informationPATIENT INFORMATION LEAFLET
Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PRED FORTE Sterile Eye Suspension, prednisolone acetate 10 mg/ml sterile eye suspension
More informationDUOTRAV Eye Drops travoprost 0.004% and timolol 0.5%
DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Alcon (Australia) Pty Ltd Consumer Medicine Information What is in this Leaflet This leaflet answers some common questions about DUOTRAV Eye Drops.
More informationPackage leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol
Package leaflet: Information for the user GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate
Package leaflet: Information for the patient Brimonidine Biogaran 2 mg/ml eye drops, solution brimonidine tartrate Read all of this leaflet carefully before you start using this medicine because it contains
More informationPharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS:
0BCore Safety Profile Active substance: Betaxolol eyedrops Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS: HU/H/PSUR/0010/002 Date of FAR: 20.03.2013 4.2 Posology
More informationPATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops
Page 1 of 6 SCHEDULING STATUS Schedule 4 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Read all of this leaflet carefully
More informationPilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Pilocarpine 2% w/v Eye Drops, solution Pilocarpine 4% w/v Eye Drops, solution Pilocarpine Hydrochloride (Referred to as Pilocarpine Eye Drops in this leaflet)
More informationPackage Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac
Package Leaflet: Information for the user NEVANAC 3 mg/ml eye drops, suspension nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPackage Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost
Package Leaflet: Information for the user LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Read all of this leaflet carefully before you start using this medicine because it
More informationCONSUMER INFORMATION. Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative
CONSUMER INFORMATION Pr Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative This leaflet is designed specifically for Consumers.
More informationPackage leaflet: Information for the user. AZOPT 10 mg/ml eye drops, suspension Brinzolamide
Package leaflet: Information for the user AZOPT 10 mg/ml eye drops, suspension Brinzolamide Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops
Page 1 of 5 SCHEDULING STATUS Schedule 2 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops Read all of this leaflet
More informationLUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)
LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about LUMIGAN eye drops. It does not contain all the available
More informationPRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate
Package leaflet: Information for the user PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Read all of this leaflet carefully before you start using this medicine because it contains important
More informationTENOPT timolol maleate
TENOPT timolol maleate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information. It does not take the place
More informationPackage leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin
Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution Levofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationALPHAGAN EYE DROPS BRIMONIDINE TARTRATE
PACKAGE LEAFLET: INFORMATION FOR THE USER ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationPackage leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container Bimatoprost/timolol
Package leaflet: Information for the user GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container Bimatoprost/timolol Read all of this leaflet carefully before you start using this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)
PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol) Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may
More informationAPO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)
APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet
More informationCONSUMER MEDICINE INFORMATION
CONSUMER MEDICINE INFORMATION Arrow Dortim Dorzolamide 2% and Timolol 0.5% Eye Drops, Solution What is in this leaflet This leaflet answers some common questions about ARROW-DORTIM. It does not contain
More informationZADITEN Eye Drops 1.0%
ZADITEN Eye Drops 1.0% Ketotifen Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you use Zaditen Eye Drops. This leaflet answers some common questions about
More informationDUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Consumer Medicine Information
DUOTRAV travoprost 0.004% and timolol 0.5% Consumer Medicine Information What is in this Leaflet Read this leaflet carefully before you start to use DuoTrav Eye This leaflet answers some common questions
More informationTOBRADEX TM Eye Drops
TOBRADEX TM Eye Drops Tobramycin and Dexamethasone CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Tobradex Eye This leaflet answers some common
More informationCILOXAN TM Eye Drops 0.3%
CILOXAN TM Eye Drops 0.3% ciprofloxacin hydrochloride CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Ciloxan Eye Drops. This leaflet answers some
More informationPackage leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost
Package leaflet: Information for the user Xalatan 50 micrograms/ml Eye drops, solution Latanoprost Read all of this leaflet carefully before you start using this medicine because it contains important
More informationCore Safety Profile. Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% Date of FAR:
Core Safety Profile Active substance: Carteolol Pharmaceutical form(s)/strength: Sterile eye drops 1%, 2% P - RMS: SK/H/PSUR/0002/002 Date of FAR: 16.03.2012 4.1 THERAPEUTIC INDICATIONS Ocular hypertension
More informationWhat Maxitrol Eye Drops is used for
MAXITROL Dexamethasone, Neomycin and Polymyxin B CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use This leaflet answers some common questions about
More informationPatient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5%
Patient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5% Read this information before you start using COSOPT PF and each time you get a refill.
More informationPackage Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)
Package Leaflet : Information for the User IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You
More informationBefore prescribing DUOTRAV Eye Drops for you, your doctor will have examined the eye and decided that DUOTRAV Eye Drops is the right medicine.
DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Consumer Medicine Information What is in this Leaflet Read this leaflet carefully before you start to use This leaflet answers some common questions
More informationPATIENT INFORMATION LEAFLET
Page 1 PATIENT INFORMATION LEAFLET Please read this leaflet carefully before using COMBIGAN. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor
More informationPRESCRIBING INFORMATION AND CONSUMER INFORMATION ISOPTO * CARPINE. pilocarpine hydrochloride ophthalmic solution, USP.
PRESCRIBING INFORMATION AND CONSUMER INFORMATION Pr ISOPTO * CARPINE pilocarpine hydrochloride ophthalmic solution, USP 1%, 2% and 4% w/v Parasympathomimetic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga,
More informationENIDIN EYE DROPS [brimonidine tartrate]
ENIDIN EYE DROPS [brimonidine tartrate] Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ENIDIN eye drops, including how to use the eye It does not
More informationTOBREX TM EYE DROPS and EYE OINTMENT 0.3%
TOBREX TM EYE DROPS and EYE OINTMENT 0.3% Tobramycin Consumer Medicine Information What is in this leaflet Read this leaflet carefully before you start to use Tobrex Eye Drops and Eye Ointment. This leaflet
More informationPackage leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin
Package leaflet: Information for the user 3 mg/ml eye drops, solution Ofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
More informationDORZOLAMIDE/ TIMOLOL SANDOZ 20/5
TIMOLOL SANDOZ dorzolamide hydrochloride / timolol maleate eye drops Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available
More informationAPO-Latanoprost Contains the active ingredient latanoprost
APO-Latanoprost Contains the active ingredient latanoprost Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet carefully before
More informationPackage leaflet: Information for the patient. Brinzolamide 10 mg/ml Eye Drops, Suspension brinzolamide
Package leaflet: Information for the patient Brinzolamide 10 mg/ml Eye Drops, Suspension brinzolamide Read all of this leaflet carefully before you start using this medicine because it contains important
More informationMAXIDEX Eye Drops 0.1%
MAXIDEX Eye Drops 0.1% Dexamethasone CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Maxidex Eye Drops. This leaflet answers some common questions
More informationCOSDOR. What is in this leaflet. Before you use COSDOR. What COSDOR is used for. Dorzolamide hydrochloride/timolol maleate
Dorzolamide hydrochloride/timolol maleate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about COSDOR. It does not contain all the available information.
More informationPackage leaflet: Information for the user XATABLOC. 50 micrograms/ml + 5 mg/ml eye drops, solution latanoprost / timolol
Package leaflet: Information for the user XATABLOC 50 micrograms/ml + 5 mg/ml eye drops, solution latanoprost / timolol Read all of this leaflet carefully before you start using this medicine because it
More informationPackage leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost
Package leaflet: Information for the user Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost Read all of this leaflet carefully before you start using this medicine because it contains
More informationTRAVATAN Eye Drops 0.004% travoprost
Eye Drops 0.004% travoprost Consumer Medicine Information What is in this leaflet Read this leaflet carefully before you start to use Travatan Eye Drops. This leaflet answers some common questions about
More informationVOLTAREN OPHTHA Eye Drops 0.1%
VOLTAREN OPHTHA Eye Drops 0.1% Diclofenac sodium CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Voltaren Eye Drops. This leaflet answers some
More informationPackage leaflet: Information for the user. Optilamid 10 mg/ml, oogdruppels, suspensie Brinzolamide
Package leaflet: Information for the user Optilamid 10 mg/ml, oogdruppels, suspensie Brinzolamide Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationSome general information on hepatitis A infection is given at the end of this leaflet.
Package Leaflet: Information for the User Havrix Monodose Vaccine Suspension for injection in a pre-filled syringe Hepatitis A (inactivated) vaccine (adsorbed) Read all of this leaflet carefully before
More informationPRESCRIBING INFORMATION
PRESCRIBING INFORMATION OPTIMYXIN Gramicidin and Polymyxin B Sulfate Oto-Ophthalmic Solution sterile Eye/Ear Drops Antibiotic Sandoz Canada Inc. Date of Revision: November 25, 2015 145 Jules-Léger Boucherville,
More informationCILOXAN 0.3% Ear Drops
CILOXAN 0.3% Ear Drops ciprofloxacin hydrochloride Alcon Laboratories (Australia) Pty Ltd CONSUMER MEDICINE INFORMATION What is in this Leaflet This leaflet answers some common questions about Ciloxan.
More informationIOPIDINE Eye Drops 0.5%
IOPIDINE Eye Drops 0.5% Apraclonidine hydrochloride CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Iopidine Eye Drops. This leaflet answers some
More informationAZOPT EYE DROPS 1% What is in this leaflet. Before you use Azopt. What Azopt is used for. Brinzolamide. Consumer Medicine Information.
Brinzolamide Consumer Medicine Information What is in this leaflet Read this leaflet carefully before you start to use Azopt Eye Drops. This leaflet answers some common questions about Azopt. It does not
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5%
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION XIIDRA TM* Lifitegrast Ophthalmic Solution 5% Read this carefully before you start taking XIIDRA and each time you get
More informationPackage leaflet: Information for the user. COMBIGAN 2 mg/ml + 5 mg/ml eye drops, solution Brimonidine tartrate and timolol
Package leaflet: Information for the user COMBIGAN 2 mg/ml + 5 mg/ml eye drops, solution Brimonidine tartrate and timolol Read all of this leaflet carefully before you start using this medicine because
More informationPATIENT INFORMATION LEAFLET
ENFLUAT 0.4 % Sterile Eye Drops Applied dropwise to the eye. PATIENT INFORMATION LEAFLET Drug substance: Each 1ml contains 4 mg ketorolac tromethamine. Excipient(s): Benzalconium chloride, sodium chloride,
More informationPackage leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride
Package leaflet: Information for the user Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v.
PRESCRIBING INFORMATION WITH CONSUMER INFORMATION Pr MYDRIACYL tropicamide ophthalmic solution, USP 0.5% and 1% w/v Anticholinergic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga, ON L5N 8C7 www.alcon.ca
More informationPackage leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin
Package leaflet: Information for the patient Verkazia 1 mg/ml eye drops emulsion ciclosporin Read all of this leaflet carefully before you start using this medicine because it contains important information
More information2 pl-timoptol-la-uk-appr
Package leaflet: Information for the patient Timoptol-LA 0.25% w/v gel-forming eye drops, solution Timoptol-LA 0.5% w/v gel-forming eye drops, solution timolol (as maleate) Read all of this leaflet carefully
More informationCIPROXIN HC Ear Drops
CIPROXIN HC Ear Drops Ciprofloxacin and Hydrocortisone CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you use. This leaflet answers some common questions
More informationHavrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe
GSK (logo) Package Leaflet: Information for the User Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed). 1440 ELISA Units/1 ml Suspension for Injection in a pre-filled syringe Read all
More informationDUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Consumer Medicine Information
DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Consumer Medicine Information What is in this Leaflet Read this leaflet carefully before you start to use DuoTrav Eye Drops. This leaflet answers some
More informationISOPTO CARPINE Eye Drops
ISOPTO CARPINE Eye Drops 1%, 2% and 4% Pilocarpine hydrochloride Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you use any ISOPTO CARPINE Eye Drops. This
More informationTRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.
TRIPROLIDINE New Zealand Consumer Medicine Information What is in this leaflet The medicine you have purchased contains triprolidine. This leaflet is intended to provide information on the active ingredient
More informationNAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%.
NEW ZEALAND DATA SHEET 1. PRODUCT NAME NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Naphcon-A contains naphazoline hydrochloride
More informationPackage leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide
Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin
Package leaflet: Information for the patient IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate
PACKAGE LEAFLET: INFORMATION FOR THE USER GRAZAX 75,000 SQ-T oral lyophilisate Standardised allergen extract of grass pollen from Timothy (Phleum pratense) Read all of this leaflet carefully before you
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone
PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You
More informationLATANOPROST-TIMOLOL ALPHAPHARM 50/5 eye drops contains the active ingredients latanoprost and timolol (as maleate)
eye drops contains the active ingredients latanoprost and timolol (as maleate) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain
More informationPackage leaflet: Information for the user. DuoTrav 40 micrograms/ml + 5 mg/ml eye drops, solution travoprost/timolol
Package leaflet: Information for the user DuoTrav 40 micrograms/ml + 5 mg/ml eye drops, solution travoprost/timolol Read all of this leaflet carefully before you start using this medicine because it contains
More informationPATIENT INFORMATION LEAFLET AMLOC RANGE
SCHEDULING STATUS: S3 PROPRIETARY NAME AND DOSAGE FORM: AMLOC 5 mg tablets AMLOC 10 mg tablet Read all of this leaflet carefully before you start taking AMLOC. Keep this leaflet. You may need to read it
More informationTAFEN NASAL 50mcg nasal spray, suspension
PACKAGE LEAFLET: INFORMATION FOR THE USER TAFEN NASAL 50mcg nasal spray, suspension BUDESONIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationLATANOPROST / TIMOLOL SANDOZ
LATANOPROST / TIMOLOL SANDOZ maleate Eye Drops Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about drops. It does not contain all the available information.
More informationPATIENT INFORMATION LEAFLET
N-CORT 0.055% nasal spray, suspension It is used by spraying into the nose. Active substance: (w/w%) Triamcinolone acetonide 0.055 PATIENT INFORMATION LEAFLET Excipients: Benzalkonium chloride 50%, sodium
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride Read all of this leaflet carefully before you start using this
More informationPATIENT INFORMATION LEAFLET
PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.
More informationKAMIREN PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT KAMIREN IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER KAMIREN 2 mg, 4 mg TABLETS DOXAZOSIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationPemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)
Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet
More informationMURINE HAYFEVER RELIEF 2% W/V EYE DROPS Sodium Cromoglicate
MURINE HAYFEVER RELIEF 2% W/V EYE DROPS Sodium Cromoglicate Read this leaflet carefully before you start using this medicine. This medicine is available without a prescription, however you still need to
More informationMAXITROL Eye Ointment
MAXITROL Dexamethasone, Neomycin and Polymyxin B CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Maxitrol. This leaflet answers some common questions
More informationPATIENT INFORMATION LEAFLET
N-CORT 0.055% Nasal Spray For nasal use. PATIENT INFORMATION LEAFLET Active substance(s): Triamcinolone acetonide (w/w%) 0.055 Excipient(s): Benzalkonium chloride 50%, sodium hydroxide, hydrochloric acid,
More informationPackage leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate
Package leaflet: Information for the user Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate Read all of this leaflet carefully before you start using this medicine because it contains
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION Pr AVAMYS fluticasone furoate nasal spray FOR NASAL USE ONLY This leaflet is part III of a three-part "Product Monograph" published when AVAMYS was approved for sale in Canada
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Xylo-COMOD
PACKAGE LEAFLET: INFORMATION FOR THE USER Xylo-COMOD Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you
More informationPackage leaflet: Information for the user. SIMBRINZA 10 mg/ml + 2 mg/ml eye drops, suspension Brinzolamide/brimonidine tartrate
Package leaflet: Information for the user SIMBRINZA 10 mg/ml + 2 mg/ml eye drops, suspension Brinzolamide/brimonidine tartrate Read all of this leaflet carefully before you start using this medicine because
More information